Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity

Ajay A. Sapre, Gen Yong, Ya san Yeh, Laura E. Ruff, Justin S. Plaut, Zeynep Sayar, Anupriya Agarwal, Jacqueline Martinez, Theresa N. Nguyen, Yu Tsueng Liu, Bradley T. Messmer, Sadik Esener, Jared Fischer

Research output: Contribution to journalArticle

Abstract

Viral gene therapy is a means of delivering genes to replace malfunctioning ones, to kill cancer cells, or to correct genetic mutations. This technology is emerging as a powerful clinical tool; however, it is still limited by viral tropism, uptake and clearance by the liver, and most importantly an immune response. To overcome these challenges, we sought to merge the robustness of viral gene expression and the versatility of nanoparticle technology. Here, we describe a method for cloaking adenovirus (Ad) in silica (SiAd) as a nanoparticle formulation that significantly enhances transduction. Intratumoral injections in human glioma xenografts revealed SiAd expressing luciferase improved tumor transduction while reducing liver uptake. In immune-competent mice SiAd induced no inflammatory cytokines and reduced production of neutralizing antibodies. Finally, SiAd expressing TNF-related apoptosis-inducing ligand inhibited tumor growth of glioma xenografts. These results reveal that silica cloaking of Ad can enhance viral gene delivery while reducing immunogenicity.

Original languageEnglish (US)
Pages (from-to)48-59
Number of pages12
JournalJournal of Controlled Release
Volume297
DOIs
StatePublished - Mar 10 2019

Fingerprint

Viral Genes
Adenoviridae
Silicon Dioxide
Heterografts
Glioma
Nanoparticles
Viral Tropism
TNF-Related Apoptosis-Inducing Ligand
Genes
Technology
Neoplasms
Liver
Neutralizing Antibodies
Luciferases
Genetic Therapy
Cytokines
Gene Expression
Mutation
Injections
Growth

Keywords

  • Adenovirus
  • Gene delivery
  • Gene therapy
  • Nanoparticle
  • Silica

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this

Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity. / Sapre, Ajay A.; Yong, Gen; Yeh, Ya san; Ruff, Laura E.; Plaut, Justin S.; Sayar, Zeynep; Agarwal, Anupriya; Martinez, Jacqueline; Nguyen, Theresa N.; Liu, Yu Tsueng; Messmer, Bradley T.; Esener, Sadik; Fischer, Jared.

In: Journal of Controlled Release, Vol. 297, 10.03.2019, p. 48-59.

Research output: Contribution to journalArticle

Sapre, AA, Yong, G, Yeh, YS, Ruff, LE, Plaut, JS, Sayar, Z, Agarwal, A, Martinez, J, Nguyen, TN, Liu, YT, Messmer, BT, Esener, S & Fischer, J 2019, 'Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity', Journal of Controlled Release, vol. 297, pp. 48-59. https://doi.org/10.1016/j.jconrel.2019.01.034
Sapre, Ajay A. ; Yong, Gen ; Yeh, Ya san ; Ruff, Laura E. ; Plaut, Justin S. ; Sayar, Zeynep ; Agarwal, Anupriya ; Martinez, Jacqueline ; Nguyen, Theresa N. ; Liu, Yu Tsueng ; Messmer, Bradley T. ; Esener, Sadik ; Fischer, Jared. / Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity. In: Journal of Controlled Release. 2019 ; Vol. 297. pp. 48-59.
@article{007e1a1ebe354c95afa501b564dfecdf,
title = "Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity",
abstract = "Viral gene therapy is a means of delivering genes to replace malfunctioning ones, to kill cancer cells, or to correct genetic mutations. This technology is emerging as a powerful clinical tool; however, it is still limited by viral tropism, uptake and clearance by the liver, and most importantly an immune response. To overcome these challenges, we sought to merge the robustness of viral gene expression and the versatility of nanoparticle technology. Here, we describe a method for cloaking adenovirus (Ad) in silica (SiAd) as a nanoparticle formulation that significantly enhances transduction. Intratumoral injections in human glioma xenografts revealed SiAd expressing luciferase improved tumor transduction while reducing liver uptake. In immune-competent mice SiAd induced no inflammatory cytokines and reduced production of neutralizing antibodies. Finally, SiAd expressing TNF-related apoptosis-inducing ligand inhibited tumor growth of glioma xenografts. These results reveal that silica cloaking of Ad can enhance viral gene delivery while reducing immunogenicity.",
keywords = "Adenovirus, Gene delivery, Gene therapy, Nanoparticle, Silica",
author = "Sapre, {Ajay A.} and Gen Yong and Yeh, {Ya san} and Ruff, {Laura E.} and Plaut, {Justin S.} and Zeynep Sayar and Anupriya Agarwal and Jacqueline Martinez and Nguyen, {Theresa N.} and Liu, {Yu Tsueng} and Messmer, {Bradley T.} and Sadik Esener and Jared Fischer",
year = "2019",
month = "3",
day = "10",
doi = "10.1016/j.jconrel.2019.01.034",
language = "English (US)",
volume = "297",
pages = "48--59",
journal = "Journal of Controlled Release",
issn = "0168-3659",
publisher = "Elsevier",

}

TY - JOUR

T1 - Silica cloaking of adenovirus enhances gene delivery while reducing immunogenicity

AU - Sapre, Ajay A.

AU - Yong, Gen

AU - Yeh, Ya san

AU - Ruff, Laura E.

AU - Plaut, Justin S.

AU - Sayar, Zeynep

AU - Agarwal, Anupriya

AU - Martinez, Jacqueline

AU - Nguyen, Theresa N.

AU - Liu, Yu Tsueng

AU - Messmer, Bradley T.

AU - Esener, Sadik

AU - Fischer, Jared

PY - 2019/3/10

Y1 - 2019/3/10

N2 - Viral gene therapy is a means of delivering genes to replace malfunctioning ones, to kill cancer cells, or to correct genetic mutations. This technology is emerging as a powerful clinical tool; however, it is still limited by viral tropism, uptake and clearance by the liver, and most importantly an immune response. To overcome these challenges, we sought to merge the robustness of viral gene expression and the versatility of nanoparticle technology. Here, we describe a method for cloaking adenovirus (Ad) in silica (SiAd) as a nanoparticle formulation that significantly enhances transduction. Intratumoral injections in human glioma xenografts revealed SiAd expressing luciferase improved tumor transduction while reducing liver uptake. In immune-competent mice SiAd induced no inflammatory cytokines and reduced production of neutralizing antibodies. Finally, SiAd expressing TNF-related apoptosis-inducing ligand inhibited tumor growth of glioma xenografts. These results reveal that silica cloaking of Ad can enhance viral gene delivery while reducing immunogenicity.

AB - Viral gene therapy is a means of delivering genes to replace malfunctioning ones, to kill cancer cells, or to correct genetic mutations. This technology is emerging as a powerful clinical tool; however, it is still limited by viral tropism, uptake and clearance by the liver, and most importantly an immune response. To overcome these challenges, we sought to merge the robustness of viral gene expression and the versatility of nanoparticle technology. Here, we describe a method for cloaking adenovirus (Ad) in silica (SiAd) as a nanoparticle formulation that significantly enhances transduction. Intratumoral injections in human glioma xenografts revealed SiAd expressing luciferase improved tumor transduction while reducing liver uptake. In immune-competent mice SiAd induced no inflammatory cytokines and reduced production of neutralizing antibodies. Finally, SiAd expressing TNF-related apoptosis-inducing ligand inhibited tumor growth of glioma xenografts. These results reveal that silica cloaking of Ad can enhance viral gene delivery while reducing immunogenicity.

KW - Adenovirus

KW - Gene delivery

KW - Gene therapy

KW - Nanoparticle

KW - Silica

UR - http://www.scopus.com/inward/record.url?scp=85060768715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85060768715&partnerID=8YFLogxK

U2 - 10.1016/j.jconrel.2019.01.034

DO - 10.1016/j.jconrel.2019.01.034

M3 - Article

VL - 297

SP - 48

EP - 59

JO - Journal of Controlled Release

JF - Journal of Controlled Release

SN - 0168-3659

ER -